Mitochondrial medicine and the neurodegenerative mitochondriopathies
Open accessAbstract
Neurodegenerative diseases are a common late-life scourge for which disease-modifying treatments are sorely needed. Mitochondrial perturbation is commonly observed in these diseases, so pursuing treatment development strategies that target mitochondria or processes affected by mitochondria seems reasonable. This review discusses the rationale underlying past and current efforts to treat neurodegenerative diseases using mitochondrial medicine, and tries to predict how future efforts might proceed.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Mitochondrial dysfunction initiates LOAD.
“Finally, as we believe mitochondrial dysfunction initiates LOAD, we would instead advocate developing mitochondrial or bioenergetic medicine approaches for the treatment of LOAD [263-266].”
From The Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives (2014) · cites this paper as [264]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197 · see citing works
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914 · see citing works
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960 · see citing works
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T., Mackenzie, G., Garcia-Osuna, M., Panov, A., & Greenamyre, J. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,797 · see citing works
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577 · see citing works
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380 · see citing works
Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2007) · JAMA · doi:10.1001/jama.297.8.842 · Cited by 2,275 · see citing works
Practice parameter: Management of dementia (an evidence-based review) [RETIRED]
Doody, R. S., Stevens, J. E., Beck, C., Dubinsky, R., Kaye, J. A., Gwyther, L. P., Mohs, R. C., Thal, L. J., Whitehouse, P. J., DeKosky, S. T., et al. (2001) · Neurology · doi:10.1212/wnl.56.9.1154 · Cited by 1,703 · see citing works
Apoptosis in neurodegenerative disorders
Mattson, M. P. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35040009 · Cited by 1,605 · see citing works
Antioxidants prevent health-promoting effects of physical exercise in humans
Ristow, M., Zarse, K., Oberbach, A., Klöting, N., Birringer, M., Kiehntopf, M., Stumvoll, M., Kahn, C. R., & Blüher, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903485106 · Cited by 1,582 · see citing works
Bender, A., Krishnan, K. J., Morris, C. M., Taylor, G. A., Reeve, A. K., Perry, R. H., Jaros, E., Hersheson, J. S., Betts, J., Klopstock, T., et al. (2006) · Nature Genetics · doi:10.1038/ng1769 · Cited by 1,570 · see citing works
Aging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,434 · see citing works
Oxidant signals and oxidative stress
Finkel, T. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00002-4 · Cited by 1,393 · see citing works
Mitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367 · see citing works
ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease
Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., et al. (2004) · Science · doi:10.1126/science.1091230 · Cited by 1,303 · see citing works
Mammalian sirtuins—emerging roles in physiology, aging, and calorie restriction
Haigis, M. C., & Guarente, L. P. (2006) · Genes & Development · doi:10.1101/gad.1467506 · Cited by 1,295 · see citing works
Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease
Wang, X., Su, B., Lee, H.-G., Li, X., Perry, G., Smith, M. A., & Zhu, X. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1357-09.2009 · Cited by 1,224 · see citing works
Schulz, T. J., Zarse, K., Voigt, A., Urban, N., Birringer, M., & Ristow, M. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.08.011 · Cited by 1,209 · see citing works
Selective Targeting of a Redox-active Ubiquinone to Mitochondria within Cells
Kelso, G. F., Porteous, C. M., Coulter, C. V., Hughes, G., Porteous, W. K., Ledgerwood, E. C., Smith, R. A. J., & Murphy, M. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009093200 · Cited by 1,091 · see citing works
Dietary Intake of Antioxidants and Risk of Alzheimer Disease
Engelhart, M. J. (2002) · JAMA · doi:10.1001/jama.287.24.3223 · Cited by 1,080 · see citing works
Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V. O., Li, M., Sarang, S. S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,071 · see citing works
Abnormalities of the electron transport chain in idiopathic parkinson's disease
Parker, W. D., Boyson, S. J., & Parks, J. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260606 · Cited by 1,061 · see citing works
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines
Panov, A. V., Gutekunst, C.-A., Leavitt, B. R., Hayden, M. R., Burke, J. R., Strittmatter, W. J., & Greenamyre, J. T. (2002) · Nature Neuroscience · doi:10.1038/nn884 · Cited by 1,030 · see citing works
Cui, L., Jeong, H., Borovecki, F., Parkhurst, C. N., Tanese, N., & Krainc, D. (2006) · Cell · doi:10.1016/j.cell.2006.09.015 · Cited by 1,012 · see citing works
Effects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline
Shults, C. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1541 · Cited by 984 · see citing works
Toxic proteins released from mitochondria in cell death
Saelens, X., Festjens, N., Walle, L. V., van Gurp, M., Loo, G., & Vandenabeele, P. (2004) · Oncogene · doi:10.1038/sj.onc.1207523 · Cited by 977 · see citing works
Yao, J., Irwin, R. W., Zhao, L., Nilsen, J., Hamilton, R. T., & Brinton, R. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903563106 · Cited by 940 · see citing works
Du, H., Guo, L., Fang, F., Chen, D., Sosunov, A. A., McKhann, G. M., Yan, Y., Wang, C., Zhang, H., Molkentin, J. D., et al. (2008) · Nature Medicine · doi:10.1038/nm.1868 · Cited by 935 · see citing works
Kraytsberg, Y., Kudryavtseva, E., McKee, A. C., Geula, C., Kowall, N. W., & Khrapko, K. (2006) · Nature Genetics · doi:10.1038/ng1778 · Cited by 884 · see citing works
Gomez-Cabrera, M.-C., Domenech, E., Romagnoli, M., Arduini, A., Borras, C., Pallardo, F. V., Sastre, J., & Viña, J. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.1.142 · Cited by 844 · see citing works
Devi, L., Prabhu, B. M., Galati, D. F., Avadhani, N. G., & Anandatheerthavarada, H. K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1469-06.2006 · Cited by 792 · see citing works
A “mitochondrial cascade hypothesis” for sporadic Alzheimer’s disease
Swerdlow, R. H., & Khan, S. M. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.12.045 · Cited by 758 · see citing works
Weindruch, R. H., & Sohal, R. S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371407 · Cited by 743 · see citing works
Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease
Caspersen, C., Wang, N., Yao, J., Sosunov, A., Chen, X., Lustbader, J. W., Xu, H. W., Stern, D., McKhann, G., & Du Yan, S. (2005) · The FASEB Journal · doi:10.1096/fj.05-3735fje · Cited by 738 · see citing works
Risner, M. E., Saunders, A. M., Altman, J. F. B., Ormandy, G. C., Craft, S., Foley, I. M., Zvartau-Hind, M. E., Hosford, D. A., Roses, A. D., & for the Rosiglitazone in Alzheimer's Disease Study Group (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500369 · Cited by 686 · see citing works
Mitochondrial calcium and the permeability transition in cell death
Lemasters, J. J., Theruvath, T. P., Zhong, Z., & Nieminen, A. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.06.009 · Cited by 656 · see citing works
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Gordon, P. H., Moore, D. H., Miller, R. G., Florence, J. M., Verheijde, J. L., Doorish, C., Hilton, J. F., Spitalny, G. M., MacArthur, R. B., Mitsumoto, H., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70270-3 · Cited by 649 · see citing works
The mitochondrial energy transduction system and the aging process
Navarro, A., & Boveris, A. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00213.2006 · Cited by 646 · see citing works
Origin and functional consequences of the complex I defect in Parkinson's disease
Swerdlow, R. H., Parks, J. K., Miller, S. W., Davis, R. E., Tuttle, J. B., Trimmer, P. A., Sheehan, J. P., Bennett, J. P., & Parker, W. D. (1996) · Annals of Neurology · doi:10.1002/ana.410400417 · Cited by 638 · see citing works
Cytochrome oxidase deficiency in Alzheimer’s disease
Parker, W. D., Filley, C. M., & Parks, J. K. (1990) · Neurology · doi:10.1212/wnl.40.8.1302 · Cited by 598 · cited 1× · see citing works
“The most specific defect involves a reduction in the complex IV (cytochrome oxidase) Vmax activity [6].”
BackgroundPractice parameter: Management of dementia (an evidence-based review)
Oken, B. (2001) · Neurology · doi:10.1212/wnl.57.12.2323 · Cited by 578 · see citing works
Greer, E. L., & Brunet, A. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00459.x · Cited by 574 · see citing works
Feron, O. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.06.025 · Cited by 559 · see citing works
Resveratrol: A multitargeted agent for age-associated chronic diseases
Harikumar, K. B., & Aggarwal, B. B. (2008) · Cell Cycle · doi:10.4161/cc.7.8.5740 · Cited by 552 · see citing works
Henderson, S. T., Vogel, J. L., Barr, L. J., Garvin, F., Jones, J. J., & Costantini, L. C. (2009) · Nutrition & Metabolism · doi:10.1186/1743-7075-6-31 · Cited by 548 · see citing works
Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin
Koutníková, H., Campuzano, V., Foury, F., Dollé, P., Cazzalini, O., & Koenig, M. (1997) · Nature Genetics · doi:10.1038/ng0897-345 · Cited by 473 · see citing works
Pioglitazone Induces Mitochondrial Biogenesis in Human Subcutaneous Adipose Tissue In Vivo
Bogacka, I., Xie, H., Bray, G. A., & Smith, S. R. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1392 · Cited by 467 · see citing works
Doody, R. S., Si, G., Sano, M. C., Thomas, R. G., Aisen, P. S. S., Бачурин, С. О., Seely, L., & Hung, D. S.-Y. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61074-0 · Cited by 460 · see citing works
Ji, L. L., Gómez‐Cabrera, M. C., & Viña, J. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1354.061 · Cited by 445 · see citing works
Ketone Bodies, Potential Therapeutic Uses
Veech, R. L., Chance, B., Kashiwaya, Y., Lardy, H. A., & Cahill, G. F. (2001) · IUBMB Life · doi:10.1080/152165401753311780 · Cited by 427 · see citing works
Gabuzda, D., Busciglio, J., Chen, L. B., Matsudaira, P., & Yankner, B. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36875-8 · Cited by 373 · see citing works
Sirtuins in Aging and DiseasePreprint
Guarente, L. (2007) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2007.72.024 · Cited by 371 · see citing works
Reddy, P. H., McWeeney, S. K., Park, B. S., Mańczak, M., Gutala, R. V., Partovi, D., Jung, Y., Yau, V., Searles, R. P., Mori, M., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh140 · Cited by 327 · see citing works
Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease
Büeler, H. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.006 · Cited by 326 · see citing works
The development of mitochondrial medicine.
Luft, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8731 · Cited by 302 · see citing works
Reactive Oxygen Species and Signal Transduction
Finkel, T. (2001) · IUBMB Life · doi:10.1080/15216540252774694 · Cited by 291 · see citing works
Cybrids in Alzheimer's disease: a cellular model of the disease?
Swerdlow, R. H., Parks, J. K., Cassarino, D. S., Maguire, D. J., Maguire, R. S., Bennett, J. P., Davis, R. E., & Parker, W. D. (1997) · Neurology · doi:10.1212/wnl.49.4.918 · Cited by 272 · see citing works
Plasticity of skeletal muscle mitochondria: structure and function.
HOPPELER, H., & FL??CK, M. (2003) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200301000-00016 · Cited by 267 · see citing works
Mitochondria dysfunction of Alzheimer's disease cybrids enhances Aβ toxicity
Cardoso, S. M., Santana, I. J., Swerdlow, R. H., & Oliveira, C. R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02438.x · Cited by 262 · see citing works
Cybrids in Alzheimer's disease: A cellular model of the disease?
Swerdlow, R. H., & Parker, D. W. (1998) · Neurology · doi:10.1212/wnl.51.1.326-a · Cited by 260 · see citing works
Hood, D. A. (2009) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h09-045 · Cited by 242 · see citing works
The Energetics of Huntington's Disease
Browne, S. E., & Beal, M. F. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000014824.04728.dd · Cited by 240 · see citing works
Mitochondrial Medicine: Pharmacological targeting of mitochondria in disease
Armstrong, J. S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707288 · Cited by 235 · see citing works
Idebenone treatment in Friedreich patients: One-year-long randomized placebo-controlled trial
Mariotti, C., Solari, A., Torta, D., Marano, L., Fiorentini, C., & Donato, S. D. (2003) · Neurology · doi:10.1212/01.wnl.0000055872.50364.fc · Cited by 235 · see citing works
The mitochondrial permeability transition pore
Crompton, M., Virji, S., Doyle, V., Johnson, N., & Ward, J. M. (1999) · Biochemical Society Symposia · doi:10.1042/bss0660167 · Cited by 222 · see citing works
The Alzheimer's disease mitochondrial cascade hypothesis: an update
Swerdlow, R. H., & Khan, S. M. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.01.011 · Cited by 206 · see citing works
Pandolfo, M. (2008) · Archives of Neurology · doi:10.1001/archneur.65.10.1296 · Cited by 206 · see citing works
Regulation of neuron mitochondrial biogenesis and relevance to brain health
Onyango, I. G., Lu, J., Rodova, M., Lezi, E., Crafter, A. B., & Swerdlow, R. H. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.07.014 · Cited by 188 · see citing works
Adaptation of skeletal muscle to endurance exercise
HOLLOSZY, J. O. (1975) · Medicine and Science in Sports and Exercise · doi:10.1249/00005768-197500730-00013 · Cited by 186 · see citing works
Adhihetty, P. J., & Beal, M. F. (2008) · NeuroMolecular Medicine · doi:10.1007/s12017-008-8053-y · Cited by 184 · see citing works
Rosiglitazone Induces Mitochondrial Biogenesis in Mouse Brain
Strum, J. C., Shehee, R., Virley, D. J., Richardson, J. C., Mattie, M. D., Selley, P., Ghosh, S., Nock, C. M., Saunders, A. M., & Roses, A. D. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11108 · Cited by 183 · see citing works
Mitochondria in Sporadic Amyotrophic Lateral Sclerosis
Swerdlow, R. H., Parks, J. K., Cassarino, D. S., Trimmer, P. A., Miller, S. W., Maguire, D., Sheehan, J. P., Maguire, R. S., Pattee, G. L., Juel, V. C., et al. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6866 · Cited by 180 · see citing works
Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways.
Khan, S. M., Cassarino, D. S., Abramova, N. N., Keeney, P. M., Borland, M. K., Pa, T., Krebs, C. T., Bennett, J. C., Parks, J. K., Swerdlow, R. H., et al. (2000) · PubMed · Cited by 176 · see citing works
Vitamin C and Vitamin E for Alzheimer's Disease
Boothby, L. A., & Doering, P. L. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e495 · Cited by 175 · see citing works
Mitochondria as a Target for Neurotoxins and Neuroprotective Agents
Бачурин, С. О., Shevtsova, E. F., Kireeva, E. G., Oxenkrug, G. F., & Sablin, S. O. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07541.x · Cited by 169 · see citing works
Caloric restriction: From soup to nuts
Spindler, S. R. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.10.003 · Cited by 168 · see citing works
Reddy, P. H. (2006) · BioMed Research International · doi:10.1155/jbb/2006/31372 · Cited by 153 · see citing works
Systemic and mitochondrial adaptive responses to moderate exercise in rodents
Boveris, A., & Navarro, A. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.08.015 · Cited by 151 · see citing works
Neuronal protection by sirtuins in Alzheimer's disease
Anekonda, T. S., & Reddy, P. H. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03492.x · Cited by 150 · see citing works
Stamelou, M., Reuß, A., Pilatus, U., Magerkurth, J., Niklowitz, P., Eggert, K. M., Krisp, A., Menke, T., Schade‐Brittinger, C., Oertel, W. H., et al. (2008) · Movement Disorders · doi:10.1002/mds.22023 · Cited by 150 · see citing works
Effects of acute and chronic endurance exercise on mitochondrial uncoupling in human skeletal muscle
Fernström, M., Tonkonogi, M., & Sahlin, K. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.055202 · Cited by 148 · see citing works
Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
Swerdlow, R. H. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.06.021 · Cited by 144 · see citing works
High frequency of mitochondrial complex I mutations in Parkinson’s disease and aging
Smigrodzki, R. M., Parks, J. K., & Parker, W. D. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.020 · Cited by 138 · see citing works
Oxidative Stress Involvement in α -Synuclein Oligomerization in Parkinson's Disease Cybrids
Esteves, A. R., Arduíno, D. M., Swerdlow, R. H., Oliveira, C. R., & Cardoso, S. M. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2247 · Cited by 137 · see citing works
Mitochondria in cybrids containing mtDNA from persons with mitochondriopathies
Swerdlow, R. H. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21167 · Cited by 128 · see citing works
Mitochondria in Alzheimer's disease
Swerdlow, R. H., & Kish, S. J. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)53013-0 · Cited by 126 · see citing works
Neuronal mitochondrial amelioration by feeding acetyl‐L‐carnitine and lipoic acid to aged rats
Aliev, G. M., Liu, J., Shenk, J. C., Fischbach, K., Pacheco, G. J., Chen, S. G., Obrenovich, M. E., Ward, W. F., Richardson, A. G., Smith, M. A., et al. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00324.x · Cited by 123 · see citing works
Does Antioxidant Vitamin Supplementation Protect against Muscle Damage?
McGinley, C., Shafat, A., & Donnelly, A. (2009) · Sports Medicine · doi:10.2165/11317890-000000000-00000 · Cited by 119 · see citing works
The Thiazolidinedione Pioglitazone Alters Mitochondrial Function in Human Neuron-Like Cells
Ghosh, S., Patel, N., Rahn, D. A., McAllister, J., Sadeghi, S., Horwitz, G., Berry, D., Wang, K. X., & Swerdlow, R. H. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.033845 · Cited by 116 · see citing works
The Neurodegenerative Mitochondriopathies
Swerdlow, R. H. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1095 · Cited by 112 · see citing works
Esteves, A. R., Domingues, A. F., Ferreira, I. L., Januário, C., Swerdlow, R. H., Oliveira, C. R., & Cardoso, S. M. (2008) · Mitochondrion · doi:10.1016/j.mito.2008.03.004 · Cited by 110 · see citing works
Mitochondrial ND5 mutations in idiopathic Parkinson’s disease
Parker, W. D., & Parks, J. K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.093 · Cited by 108 · see citing works
Cybrids in Alzheimer's disease: A cellular model of the disease?
Schon, E. A., Shoubridge, E. A., & Moraes, C. T. (1998) · Neurology · doi:10.1212/wnl.51.1.326 · Cited by 101 · see citing works
Therapeutic interventions for disease progression in Huntington's disease
Mestre, T., Ferreira, J. J., Coelho, M. M., Rosa, M. M., & Sampaio, C. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006455.pub2 · Cited by 100 · see citing works
Swerdlow, R. H., Golbe, L. I., Parks, J. K., Cassarino, D. S., Binder, D. R., Grawey, A. E., Litvan, I., Bennett, J. P., Wooten, G. F., & Parker, W. D. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751681.x · Cited by 95 · see citing works
Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease
Anandatheerthavarada, H. K., & Devi, L. (2007) · The Neuroscientist · doi:10.1177/1073858407303536 · Cited by 95 · see citing works
Plasticity of skeletal muscle mitochondria: structure and function.
Hoppeler, H. H., & Flück, M. (2003) · PubMed · doi:10.1249/01.mss.0000043292.99104.12 · Cited by 92 · see citing works
The effect of aging and caloric restriction on mitochondrial protein density and oxygen consumption
Lambert, A. J., Wang, B., Yardley, J., Edwards, J., & Merry, B. J. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2003.12.009 · Cited by 91 · see citing works
Mitochondria in the elderly: Is acetylcarnitine a rejuvenator?☆
Rosca, M. G., Lemieux, H., & Hoppel, C. L. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.06.009 · Cited by 87 · see citing works
Treating neurodegeneration by modifying mitochondria: potential solutions to a “complex” problem
Swerdlow, R. H. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1676 · Cited by 81 · see citing works
Antioxidants and other pharmacological treatments for Friedreich ataxia
Kearney, M., Orrell, R. W., Fahey, M. C., & Pandolfo, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007791.pub2 · Cited by 75 · see citing works
Further Evidence for Mitochondrial Dysfunction in Progressive Supranuclear Palsy
Albers, D. S., Swerdlow, R. H., Manfredi, G., Gajewski, C. D., Yang, L., Parker, W. D., & Beal, M. F. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7607 · Cited by 72 · see citing works
New roles for pyruvate kinase M2: working out the Warburg effect
Ferguson, E. C., & Rathmell, J. C. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.05.006 · Cited by 63 · see citing works
Plasma Levels of Antioxidants Are Not Associated with Alzheimer’s Disease or Cognitive Decline
Engelhart, M. J., Ruitenberg, A., Meijer, J., Kiliaan, A., van Swieten, J. C., Hofman, A., Witteman, J. C. M., & Breteler, M. M. B. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000082884 · Cited by 52 · see citing works
Diet, energy metabolism and mitochondrial biogenesis
Civitarese, A. E., Smith, S. R., & Ravussin, É. (2007) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3282f0ecd2 · Cited by 50 · see citing works
Mitochondrial Metabolism Modulation: A New Therapeutic Approach for Parkinsons Disease
Arduíno, D. M., Esteves, A. R., Oliveira, C. R., & Cardoso, S. M. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710790966687 · Cited by 44 · see citing works
Role of mitochondria in amyotrophic lateral sclerosis
Swerdlow, R. H., Parks, J. K., Pattee, G. L., & Parker, W. D. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820050515179 · Cited by 41 · see citing works
Training response of mitochondrial transcription factors in human skeletal muscle
Norrbom, J., Wallman, S. E., Gustafsson, T. P., Rundqvist, H., Jansson, E., & Sundberg, C. J. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.02030.x · Cited by 40 · see citing works
Why Eating Less Keeps Mitochondria Working in Aged Skeletal Muscle
Hepple, R. T. (2008) · Exercise and Sport Sciences Reviews · doi:10.1097/jes.0b013e3181877dc5 · Cited by 22 · see citing works
Drilling for Energy in Mitochondrial Disease
Haller, R. G., & Vissing, J. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.155 · Cited by 5 · see citing works
Khan (2000) · doi:10.1002/1531-8249(200008)48:2
Flagged first, then by citations
Cited by
Sorted by citations
The Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives
Swerdlow, R. H., Burns, J. M., & Khan, S. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.010 · Cited by 786 · see citing works
The Alzheimer’s Disease Mitochondrial Cascade Hypothesis
Swerdlow, R. H., Burns, J. M., & Khan, S. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100339 · Cited by 562 · see citing works
“Our hypothesis predicts therapies that enhance neuron aerobic metabolism may benefit late-onset AD patients [129,130].”
BackgroundMonogenic Mitochondrial Disorders
Koopman, W. J. H., Willems, P. H. G. M., & Smeitink, J. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1012478 · Cited by 515 · see citing works
Perez Ortiz, J. M., & Swerdlow, R. H. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14585 · Cited by 426 · see citing works
Mitochondria as a Therapeutic Target for Aging and Neurodegenerative Diseases
Reddy, P. H., & Reddy, T. P. (2011) · Current Alzheimer Research · doi:10.2174/156720511795745401 · Cited by 227 · see citing works
Relationships Between Mitochondria and Neuroinflammation: Implications for Alzheimer's Disease
Wilkins, H., & Swerdlow, R. H. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150827095102 · Cited by 122 · see citing works
Olesoxime (TRO19622): A Novel Mitochondrial-Targeted Neuroprotective Compound
Bordet, T., Berna, P. P., Abitbol, J., & Pruss, R. M. (2010) · Pharmaceuticals · doi:10.3390/ph3020345 · Cited by 121 · see citing works
Brain glucose and acetoacetate metabolism: a comparison of young and older adults
Nugent, S., Tremblay, S., Chen, K. W., Ayutyanont, N., Roontiva, A., Castellano, C., Fortier, M., Roy, M., Courchesne‐Loyer, A., Bocti, C., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.027 · Cited by 113 · see citing works
Hartman, M.-L., Shirihai, O. S., HOLBROOK, M. M., Xu, G., Kocherla, M., Shah, A. K., Fetterman, J. L., Kluge, M. A., Frame, A. A., Hamburg, N. M., et al. (2014) · Vascular Medicine · doi:10.1177/1358863x14521315 · Cited by 109 · see citing works
Mitochondria, Cybrids, Aging, and Alzheimer's Disease
Swerdlow, R. H., Koppel, S., Weidling, I., Hayley, C., Ji, Y., & Wilkins, H. M. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2016.12.017 · Cited by 106 · see citing works
Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration
Wilkins, H. M., Weidling, I. W., Ji, Y., & Swerdlow, R. H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00508 · Cited by 102 · see citing works
Targeting the Prodromal Stage of Alzheimer's Disease: Bioenergetic and Mitochondrial Opportunities
Caldwell, C. C., Yao, J., & Brinton, R. D. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0324-8 · Cited by 83 · see citing works
Mitochondrial Abnormalities in Alzheimer’s Disease
Silva, D. F., Selfridge, J. E., Lu, J., E, L., Cardoso, S. M., & Swerdlow, R. H. (2012) · Advances in Pharmacology · doi:10.1016/b978-0-12-394816-8.00003-9 · Cited by 86 · see citing works
Mitochondria as a pharmacological target: Magnum overview
Olszewska, A., & Szewczyk, A. M. (2013) · IUBMB Life · doi:10.1002/iub.1147 · Cited by 78 · see citing works
Artificial intelligence in Parkinson's disease: Early detection and diagnostic advancements
Reddy, A. P., Reddy, R. P., Roghani, A. K., Garcia, R. I., Khemka, S., Pattoor, V., Jacob, M., Reddy, P. H., & Sehar, U. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102410 · Cited by 65 · see citing works
Song, S. B., & Hwang, E. S. (2018) · Cells · doi:10.3390/cells8010011 · Cited by 55 · see citing works
Detection of mitochondria-pertinent components in exosomes
Wang, X., Weidling, I. W., Koppel, S. J., Menta, B. W., Ortiz, J. P., Kalani, A., Wilkins, H., & Swerdlow, R. H. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.09.006 · Cited by 56 · see citing works
Shen, X., Song, N., Du, X., Li, Y. H., Xie, J., & Jiang, H. F. (2017) · Scientific Reports · doi:10.1038/srep40961 · Cited by 52 · see citing works
Song, S. B., & Hwang, E. S. (2020) · Biomolecules · doi:10.3390/biom10050761 · Cited by 50 · see citing works
Swerdlow, R. H. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12394 · Cited by 50 · see citing works
Management of the aging risk factor for Parkinson's disease
Phillipson, O. T. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.10.073 · Cited by 46 · see citing works
Im, A., Chae, S., Zhang, G. J., & Lee, M. Y. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-370 · Cited by 39 · see citing works
Sayed, N. S. E., & Sayed, A. S. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02548-w · Cited by 37 · see citing works
H. Swerdlow, R. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072535 · Cited by 35 · see citing works
Hwang, E. S., & Song, S. B. (2023) · Molecules and Cells · doi:10.14348/molcells.2023.0121 · Cited by 31 · see citing works
Visual hallucinations, thalamocortical physiology and Lewy body disease: A review
Esmaeeli, S., Murphy, K. P., Swords, G. M., Ibrahim, B. A., Brown, J. W., & Llano, D. A. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.06.006 · Cited by 26 · see citing works
Jantas, D., Roman, A., Kuśmierczyk, J., Lorenc‐Koci, E., Konieczny, J., Lenda, T., & Lasoń, W. (2013) · Neurotoxicity Research · doi:10.1007/s12640-012-9374-z · Cited by 25 · see citing works
Yu, X., Zhang, R., Wei, C., Gao, Y., Yu, Y., Wang, L., Jiang, J., Zhang, X., Li, J., & Chen, X. (2021) · Animal Cells and Systems · doi:10.1080/19768354.2021.1915379 · Cited by 23 · see citing works
Jantas, D., Gręda, A., Leśkiewicz, M., Grygier, B., Pilc, A., & Lasoń, W. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2014.12.011 · Cited by 22 · see citing works
Park, Y., Jeong, Y., Son, S., & Kim, D. (2023) · BMB Reports · doi:10.5483/bmbrep.2022-0125 · Cited by 13 · see citing works
Macintosh, J., Derksen, A., Poulin, C., Braverman, N., Vanderver, A. L., Thiffault, I., Albrecht, S., & Bernard, G. (2022) · Neurogenetics · doi:10.1007/s10048-022-00683-8 · Cited by 13 · see citing works
Cronin-Furman, E. N., Barber‐Singh, J., Bergquist, K. E., Yagi, T., & Trimmer, P. A. (2019) · Biomolecules · doi:10.3390/biom9040119 · Cited by 11 · see citing works
Emerging Promise of Therapeutic Approaches Targeting Mitochondria in Neurodegenerative Disorders
Rahman, M. M., Tumpa, M. A. A., Rahaman, M. S., Islam, F., Sutradhar, P. R., Ahmed, M., Alghamdi, B. S. A., Hafeez, A., Alexiou, A. T., Perveen, A., et al. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230316150559 · Cited by 11 · see citing works
Effect of Cholinergic Signaling on Neuronal Cell Bioenergetics
Lu, J., Lezi, E., Roy, N., Hutfles, L. J., Selfridge, J. E., Funk, E., Burns, J. M., & Swerdlow, R. H. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121822 · Cited by 10 · see citing works
Targeting cellular batteries for the therapy of neurological diseases
Arora, A., Behl, T., Sehgal, A., Singh, S., Sharma, N., Mathew, B., & BUNGAU, S. G. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-14665-0 · Cited by 5 · see citing works
Song, Y. R., Leem, J. S., Dhanani, M., McKirnan, M. D., Ichikawa, Y., Braza, J., Harrington, E. O., Hammond, H. K., Roth, D. M., & Patel, H. H. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281550 · Cited by 4 · see citing works
The human extended mitochondrial metabolic network: New hubs from lipids
Palese, L. L., & Bossis, F. (2012) · Biosystems · doi:10.1016/j.biosystems.2012.04.001 · Cited by 3 · see citing works
Translation of bioenergetics therapies
Bhatti, G. K., Gupta, A., Reddy, P. H., & Bhatti, J. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819621-2.00022-x · Cited by 2 · see citing works
Targeting Mitochondria and Redox Dyshomeostasis in Brain Ageing: An Update
Cardoso, S., & Moreira, P. I. (2021) · Healthy ageing and longevity · doi:10.1007/978-3-030-84965-8_8 · Cited by 2 · see citing works
Tackling Alzheimer’s Disease by Targeting Oxidative Stress and Mitochondria
Castellani, R. J., Correia, S. C., Moreira, P. I., & Perry, G. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00018-6 · Cited by 2 · see citing works
Unraveling the Role of Mitochondria in Alzheimer’s Disease
Correia, S. C., Moreira, P. I., & Perry, G. L. (2020) · doi:10.1093/oso/9780190634230.003.0017 · Cited by 1 · see citing works
Huang, T. H. ‐., Gaczynska, M. E., & Osmulski, P. A. (2019)
Ural, K. U. K., Özalp, T., Paşa, S., Erdoğan, H., ERDOĞAN, S., & Coşkun, U. (2025) · Bozok Veterinary Sciences · doi:10.58833/bozokvetsci.1741870
- Authors
- Swerdlow, R. H.
- Affiliations
- University of Kansas (US)
- Corresponding author
- Swerdlow, Russell H.
- ORCID
- Swerdlow, Russell H.
- Venue
- Pharmaceuticals
- Publisher
- MDPI AG
- Published
- 2009-12-03
- Volume
- 2
- Issue
- 3
- Pages
- 150-167
- ISSN
- 1424-8247 (ISSN-L)
- PMC
- PMC3148068
- OpenAlex
- W1988248211
- Cited by
- 43
- References
- 111
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 4 · 2022: 1 · 2021: 3 · 2020: 4 · 2019: 5 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 2 · 2014: 3 · 2013: 7 · 2012: 3
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pharmaceuticals (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute on Aging (R01AG022407)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Keywords
- mitochondrial medicine, neurodegenerative diseases, mitochondrial disease, mitochondrial dysfunction, disease-modifying therapy, mitochondrial-targeted therapy, treatment development
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review